在COPD亚种群中因特定原因的死亡率:在英格兰对339,647人的队列研究
Hannah Whittaker1, Kieran J Rothnie2, Jennifer K Quint3
1School of Public Health and National Heart and Lung Institute, Imperial College London, London, UK h.whittaker@imperial.ac.uk.
Thorax
|June 16, 2023
概括
确定与慢性阻塞性肺病 (COPD) 死亡率相关的因素是关键. 恶化,空气流量限制和GOLD组显著影响COPD和心血管死亡风险.
科学领域:
- 肺部医学 肺部医学
- 流行病学 流行病学
- 临床研究 临床研究
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球死亡的主要原因之一.
- 确定COPD患者因特定原因死亡的特定风险因素对于有针对性的治疗干预至关重要.
- 了解这些相关性可以改善患者的治疗结果,并减少医疗保健负担.
研究的目的:
- 确定与所有原因,COPD相关和心血管 (CV) 死亡率相关的因素,在大量的COPD初级护理人群中.
- 调查恶化的频率/严重程度,COPD表型,空气流量限制和全球阻塞性肺病 (GOLD) 群体对死亡风险的影响.
- 为制定有针对性的干预措施以减少COPD患者的死亡率提供信息.
主要方法:
- 利用临床实践研究数据链接Aurum,与COPD患者队列的医院病例统计和死亡证明数据联系起来.
- 包括在2010年1月1日至2020年1月1日期间被诊断患有COPD的个人.
- 采用Cox比例危险回归和竞争性风险分析来评估基线患者特征和死亡结果之间的关联.
主要成果:
- 分析了339,647名COPD患者的队列,记录了97,882例死亡 (25.7%与COPD相关,23.3%与CV相关).
- 恶化的频率和严重程度,空气流量限制,GOLD组和COPD表型与所有原因的死亡率有显著关联.
- 恶化的增加,GOLD组B-D和较大的气流限制与COPD相关和心血管死亡率的更高风险有关.
结论:
- 较差的气流限制,较差的功能状态 (GOLD组) 和恶化是COPD所有原因死亡率的重要预测因素.
- 对CV和COPD相关死亡率的明显关联表明,需要针对特定患者特征或疾病阶段的量身定制干预措施.
- 这些发现强调了综合性COPD管理的重要性,重点是预防恶化和优化肺功能.
关键词:
慢性慢性肺炎的流行病学相关概念视频
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
367
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
367
COPD: Management Using Bronchodilators and Corticosteroids
255
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
255
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K


